Entrada Therapeutics Inc
NASDAQ:TRDA

Watchlist Manager
Entrada Therapeutics Inc Logo
Entrada Therapeutics Inc
NASDAQ:TRDA
Watchlist
Price: 15.47 USD -1.02% Market Closed
Updated: Jun 2, 2024

Entrada Therapeutics Inc
Common Stock

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Entrada Therapeutics Inc
Common Stock Peer Comparison

Comparables:
ABBV
GILD
AMGN
VRTX
REGN

Competitive Common Stock Analysis
Latest Figures & CAGR of Competitors

Company Common Stock CAGR 3Y CAGR 5Y CAGR 10Y
Entrada Therapeutics Inc
NASDAQ:TRDA
Common Stock
$3k
CAGR 3-Years
-97%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Abbvie Inc
NYSE:ABBV
Common Stock
$18m
CAGR 3-Years
0%
CAGR 5-Years
0%
CAGR 10-Years
1%
Gilead Sciences Inc
NASDAQ:GILD
Common Stock
$1m
CAGR 3-Years
0%
CAGR 5-Years
0%
CAGR 10-Years
-7%
Amgen Inc
NASDAQ:AMGN
Common Stock
$33.1B
CAGR 3-Years
1%
CAGR 5-Years
1%
CAGR 10-Years
1%
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
Common Stock
$2.6m
CAGR 3-Years
-5%
CAGR 5-Years
-3%
CAGR 10-Years
3%
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
Common Stock
$101.8k
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A

See Also

What is Entrada Therapeutics Inc's Common Stock?
Common Stock
3k USD

Based on the financial report for Dec 31, 2023, Entrada Therapeutics Inc's Common Stock amounts to 3k USD.

What is Entrada Therapeutics Inc's Common Stock growth rate?
Common Stock CAGR 3Y
-97%

The average annual Common Stock growth rates for Entrada Therapeutics Inc have been -97% over the past three years .